CALC: CalciMedica, Inc. Stock

by  •  • Comments Off on CALC: CalciMedica, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 46.47
Enterprise Value ($M) 37.32
Book Value ($M) 9.03
Book Value / Share 0.67
Price / Book 5.15
NCAV ($M) 8.50
NCAV / Share 0.63
Price / NCAV 5.46

Profitability (mra)
Return on Invested Capital (ROIC) -1.50
Return on Assets (ROA) -0.86
Return on Equity (ROE) -1.12

Liquidity (mrq)
Quick Ratio 4.15
Current Ratio 4.15

Balance Sheet (mrq) ($M)
Current Assets 15.69
Assets 16.21
Liabilities 7.18
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-14 13G/A Soleus Private Equity Fund III, L.P. 8.50
11-14 13G/A Lytton Laurence W 4.40 -37.99
11-13 13G/A Stonepine Capital Management, LLC 0.00 -100.00
11-06 13D/A Valence Investments SPV VI, LLC 9.00 4.67
02-08 13G/A Soleus Capital Master Fund, L.P. 9.99 40.96
02-07 13G/A BML Investment Partners, L.P. 2.10
02-05 13D/A Orbimed Advisors Llc 2.90 0.00
02-01 13G Aisling Capital V, LP 5.10
02-01 13G Flynn James E 9.99 844.01

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-04-29 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (AMENDMENT NO. 1) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ T
2024-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-22 2,751 26,300 10.46
2024-11-21 5,616 17,563 31.98
2024-11-20 2,423 11,601 20.89
2024-11-19 4,002 25,332 15.80
2024-11-18 11,171 36,220 30.84

(click for more detail)

Similar Companies
BPTH – Bio-Path Holdings, Inc. BTAI – BioXcel Therapeutics, Inc.
BYSI – BeyondSpring Inc. CAPR – Capricor Therapeutics, Inc.
CARA – Cara Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io